Article PDF
Avoid common mistakes on your manuscript.
References
Bernard C (1878) Les phenomenes de la vie Vol I. Librairie J-B Bailliere et Fils, Paris, p 879
Eisenbarth GS (1986) Type 1 diabetes mellitus: a chronic autoimmune disease. N Engl J Med 314:1360–1368
Czech MP (1977) Molecular basis of insulin action. Annu Rev Biochem 46:359–384
Waldhähusl W, Bratusch-Marrain P (1987) Factors regulating the disposal on an oral glucose load in normal, diabetic and obese subjects. Diabetes Metab Rev 3 (in press)
Roth J, Kahn CR, Lesniak MA, Gorden P, De Meyts P, Megyesi K, Neville DM, Gavin JR, Soll AH, Freychet P, Goldfine ID, Bar RS, Archer JA (1976) Receptors for insulin NSILA-S, and growth hormone. Application to disease states in man. Recent Progr Horm Res 31: 95–139
Gorden P, Carpentier JL, Freychet P, Orci L (1980) Internalization of potypeptide hormones: mechanism, intracellular localization and significance. Diabetologia 18: 263–274
Steiner DF (1977) Insulin today. Diabetes 26: 322–340
Czech MP (1981) Second messengers. In: Brownlee M (ed) Handbook of diabetes mellitus, islet cell function/insulin action, Vol 2. John Wiley, Chichester New York Brisbane Toronto, pp 117–149
Bessman SP (1985) The creatine-creatine phosphate energy shuttle. Annu Rev Biochem 54: 831–862
Bessman SP, Mohan C, Zaidise I (1986) Intracellular site of insulin action: mitochondrial Krebs cycle. Proc Natl Acad Sci 83: 5067–5070
Soskin S, Levine R (1952) Carbohydrate metabolism. University of Chicago Press, Chicago, pp 120–150
Trevisan R, Nosadini R, Avogaro A, Lippe G, Du Ner E, Fioretto P, Deana R, Tessari P, Tiengo A, Velussi M, Cernigoi A, Del Prato S, Crepaldi C (1986) Type 1 diabetes is characterized by insulin resistance not only with regard to glucose, but also to lipid and aminoacid metabolism. J Clin Endocrinol Metab 62: 1155–1162
Smith SR, Edgar PJ, Pozefsky T, Chetri MK, Prout TE (1975) Insulin secretion and glucose tolerance in adults with protein-calorie malnutrition. Metabolism 24:1073–1084
Sutherland DER (1981) Pancreas and islet transplantation. II. Clinical trials. Diabetologia 20: 435–450
Stiller CR, Dupre J, Gent M, Jenner MR, Keown A, Laupacis A, Martell R, Rodger NW, v. Graffenried B, Wolfe BMJ (1984) Effects of cyclosporine immunosuppression in insulin dependent diabetes mellitus of recent onset. Science 223:1362–1367
Bradley RF (1971) Diabetic ketoacidosis and coma. In: Marble A, White P, Bradley RF, Krall LP (eds) Joslin's diabetes mellitus. Lea and Febiger, Philadelphia, pp 361–416
Waldhausl W, Howorka K, Derfler K, Bratusch-Marrain PR, Holler C, Zyman H, Freyler H (1985) Failure and efficacy of insulin therapy in insulin dependent (Type 1) diabetic patients. Acta diabetol lat 22: 279–294
West KM (1978) Epidemiology of diabetes and its vasvascular lesions. Elsevier, New York, pp 153–158
Klein R, Klein BEK, Moss SE, Davis MD and Demets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520–526
Munger BL (1981) Morphological characterization of islet cell diversity. In: Cooperstein SJ, Watkins D (eds) The islets of Langerhans. Academic, New York, pp 3–34
Orci L, Baltens D, Ravazzola M, Stefan Y, Malaisse-Lagae F (1976) Pancreatic polypeptide and glucagon: non-random distribution in pancreatic islets. Life Sci 19: 1811–1815
Orci L (1982) Macro- and microdomains in the endocrine pancreas. Diabetes 31: 538–565
Floyd JC, Fajans SS, Conn JW, Knopf RF, Rull J (1966) Stimulation of insulin secretion by amino acids. J Clin Invest 45: 1487–1502
Floyd JC, Fajans SS, Conn JW, Knopf RF, Rull J (1966) Insulin secretion in response to protein ingestion. J Clin Invest 45: 1479–1486
Kipnis DM (1970) Insulin secretion in normal and diabetic individuals. Adv Intern Med 19: 103–134
Waldhausl WK, Gasic S, Bratusch-Marrain P, Nowotny P (1983) The 75-g oral glucose tolerance test: effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man. Diabetologia 25:489–495
Kleinbaum J, Shamoon H (1982) Selective counterregulatory hormones responses after oral glucose in man. J Clin Endocrinol Metab 55: 787–790
Waldhausl WK, Gasic S, Bratusch-Marrain P, Korn A, Nowotny P (1982) Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects. Am J Physiol 243: E476-E482
Waldhäusl W, Bratusch-Marrain P, Gasic S, Komjati M, Heding L (1986) Inhibition by proinsulin of endogenous, C-peptide release in healthy man. Am J Physiol 251: E139-E145
Gerich JE (1981) Somatostatin Vol 1. In: Brownlee M (ed) Diabetes mellitus. Wiley, New York, pp 297–354
Waldhausl W, Bratusch Marrain P, Dudczak R, Deutsch E (1977) The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics. J Clin Endocrinol Metab 44: 876–883
Robertson P, Porte D (1973) Adrenergic modulation of basal insulin secretion in man. Diabetes 22: 1–8
Fajans SS, Conn JW (19650) Prediabetes, subclinical diabetes and latent clinical diabetes. In: Leibel BS, Wrenshall GH (eds). On the nature and treatment of diabetes. Excerpta Medica Foundation, Amsterdam, pp 641–656
Lang A, Matthews DR, Pero J, Turner RC (1979) Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med 301: 1023–1027
Hansen BC, Jen KLC, Pek SB, Wolfe RA (1982) Rapid oscillations in plasma insulin, glucagon and glucose in obese and normal weight humans. J Clin Endocrinol Metab 54: 785–792
Vanhelder WP, Sirek S, Sirek OV, Norwich KH, Policova Z, Vanhelder T (1980) Diurnal episodic pattern of insulin secretion in the dog. Diabetes 29: 326–328
Henquin JC, Meissner HP, Schmeer W (1982) Cyclic variations of glucose induced electrical activity in pancreatic B-cells. Pflügers Arch. 393: 322–327
Waldhausl W, Bratusch-Marrain P, Kruse V, Jensen J, Nowotny P, Vierhapper H (1985) Effect of insulin antibodies on insulin pharmacokinetics and glucose utilization in insulin dependent diabetic patients. Diabetes 34: 166–173
Komjati M, Bratusch-Marrain PR, Waldhausl W (1986) Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro. Endocrinology 118:312–319
Matthews DR, Naylon BA, Jones RG, Ward GM, Turner RC (1983) Pulsatile insulin has greater hypoglycemic effect than continuous delivery. Diabetes 32: 617–621
Bratusch-Marrain PR, Komjati M, Waldhausl W (1986) Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in insulin dependent diabetic man. Diabetes 35: 922–926
Field JB (1973) Extraction of insulin by liver. Am Rev Med 24: 309–326
Eaton RP, Allen RC, Schade JS (1983) Hepatic removal of insulin in normal man: dose response to endogenous insulin secretion. J Clin Endocrinol Metab 56:1294–1300
Pinsky SM, Johnson PM (1984) The liver and biliary tract. Radiocolloid imaging. In: Freeman LM (ed) Clinical radionuclide imaging, 3rd edn. Grune & Strutton, New York, pp 835–878
Unger RH, Raskin P, Srikant CB, Orci L (1977) Glucagon and the A-cells. Rec Progr Horm Res 33: 477–517
Berson SA, Yalow RS, Bauman A, Rothschild MA, Newery K (1956) Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects. J Clin Invest 35: 170–190
Bergeron JJM, Cruz J, Khan MN, Posner BI (1985) Uptake of insulin and other ligands into receptor-rich endocytic components of target cells: the endoplasmic apparatus. Ann Rev Physiol 47: 383–403
Bratusch-Marrain P, Waldhausl W (1985) Suppression of basal, but not of glucose stimulated insulin secretion by human insulin in healthy and obese hyperinsulinemic subjects. Metabolism 34: 188–193
Waldhausl W, Bratusch-Marrain P, Gasic S, Korn A, Nowotny P (1979) Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man. Diabetologia 17: 221–227
Waldhausl W, Bratusch-Marrain P (1985) Pancreatic and hepatic response to carbohydrate ingestion. Neth J Med 28:15–19
Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubinstein AH (1975) Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55: 1278–1283
Bratusch-Marrain P, Waldhausl WK, Gasic S, Hofer A (1984) Hepatic disposal of biosynthetic human insulin and procine C-peptide in humans. Metabolism 33: 151–157
Radziuk J, McDonald TJ, Rubenstein D, Duprè J (1978) Initial splachnic extraction of ingested glucose in normal man. Metabolism 27: 657–669
Waldhäusl W, Bratusch-Marrain PR, Francesconi M, Nowotny P, Kiss A (1982) Insulin production rate in normal man as an estimate for calibration of continuous intravenous insulin infusion in insulin dependent diabetic patients. Diabetes Care 5: 18–24
Ferranini E, Björkman O, Reichard GH, Pilo A, Olsson M, Wahren J, DeFronzo R (1985) The disposal of an oral glucose load in healthy subjects. Diabetes 34: 580–588
Wahren J, Felig P, Hagenfeldt L (1978) Physical exercise and fuel homeostasis and diabetes mellitus. Diabetologia 14: 213–222
Felig P, Wahren J, Hendler R (1975) Influence of oral glucose ingestion on splanchnic glucose and gluconeogenic substrate metabolism in man. Diabetes 24: 468–475
Bratusch-Marrain P, Waldhäusl WK, Gasic S, Korn A, Nowotny P (1980) Oral glucose tolerance test: effect of different glucose loads on splanchnic carbohydrate and substrate metabolism in healthy man. Metabolism 29: 289–295
Krebs HA (1968) The effects of ethanol on metabolic activities of the liver. Adv Enzyme Regul 6: 467–480
Yki-Järvinen H, Nikkilä EA (1985) Ethanol decreases glucose utilization in healthy man. J Clin Endocrinol Metab 61: 941–945
Katz LD, Glickman MG, Rapoport S, Ferranini E, DeFronzo RA (1983) Splanchnic and peripheral disposal of oral glucose in man. Diabetes 32: 675–679
Nickelson MJ, Butterfield WJH (1971) Peripheral glucose uptake during the oral glucose tolerance in normal and obese subjects and borderline and frank diabetes. Clin J Med 40: 261–273
Jackson RA, Blix PM, Matthews JA, Morgan LM, Rubenstein AH, Nabarro JDN (1983) Comparison of peripheral glucose uptake after oral glucose loading or a mixed meal. Metabolism 32: 706–710
Rousselle J, Bückert A, Pahud P, Jequier E, Felber JP (1982) Relationship between glucose oxidation and glucose tolerance in man. Metabolism 31: 866–870
Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, Bogardus C (1986) Glucose storage is a major determinant of in vivo ‘insulin resistance’ in subjects with normal glucose tolerance. J Clin Endocrinol Metab 62: 922–927
De Feo P, Perriello G, De Cosmo S, Ventura MM, Campbell PJ, Brunetti P, Gerich JE, Bolli GB (1986) Comparison of glucose counter-regulation during short-term and prolonged hypoglycemia in normal humans. Diabetes 35: 563–569
Zinman B, Murray FT, Vranic M, Albisser AM, Leibel BS, McClean PA, Marliss EB (1977) Glucoregulation during moderate exercise in insulin treated diabetics. J Clin Endocrinol Metab 45:641–652
Lawrence RD (1926) The effects of exercise on insulin action in diabetes. Br Med J 1: 648–52
Pequignot JM, Peyrin L, Peres G (1980) Catecholamines fuel interrelationship during exercise in fasting men. J Appl Physiol 48: 109–113
Hansen I, Firth R, Haymond M, Cryer P, Rizza R (1986) The role of autoregulation of the hepatic glucose production in man. Diabetes 35: 186–191
Krzentowski G, Pirnay F, Pallikarakis N, Luyckx AS, Lacroix M, Mosora F, Lefebvre PJ (1981) Glucose utilization during exercise in normal and diabetic subjects. The role of insulin. Diabetes 30: 983–989
DeFronzo R, Ferranini E, Sato Y, Felig P, Wahren J (1981) Synergistic interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest 68: 1468–1474
James DE, Burleigh KM, Kraegen EW (1985) Time dependence of insulin action in muscle and adipose tissue in the rat in vivo. Diabetes 34:1049–1054
Bogardus C, Thuillez P, Ravussin E, Vasquez B, Namiriga M, Azhar S (1983) Effect of muscle glycogen depletion on in vivo insulin action in man. J Clin Invest 72:1605–1610
Calles J, Cunningham JJ, Nelson L, Brown N, Nadel E, Sherwin RS, Felig P (1983) Glucose turnover during recovery from intensive exercise. Diabetes 32: 734–738
Deibert DC, DeFronzo RA (1980) Epinephrine induced insulin resistance in man — a Beta-receptor mediated phenomenon. J Clin Invest 65: 717–721
Shamoon H, Hendler R, Sherwin RS (1980) Altered responsiveness to cortisol, epinephrine and glucagon in insulin-infused juvenile onset diabetes. A mechanism for diabetic instability. Diabetes 29: 284–291
Bratusch-Marrain P, Gasic S, Waldhäusl WK, Nowotny P (1984) The effect of growth hormone on splanchnic glucose and substrate metabolism following oral glucose loading in healthy man. Diabetes 33:19–25
Waldhausl WK, Gasic S, Bratusch-Marrain P, Komjati M, Korn A (1987) Effect of stress hormones on splanchnic substrate and insulin disposal following glucose ingestion in healthy man. Diabetes 36: 127–135
Bratusch-Marrain P, Waldhausl W, Grubeck-Loebenstein B, Korn A, Vierhapper H, Nowotny P (1981) The role of diabetogenic hormones on carbohydrate and lipid metabolism following oral glucose loading in insulin dependent diabetics: effects of acute hormone administration. Diabetologia 21: 387–393
Bratusch-Marrain PR (1983) Insulin counteracting hormones: Their impact on glucose metabolism. Diabetologia 24: 74–79
Waldhausl W, Kleinberger G, Korn A, Dudczak R, Bratusch-Marrain P, Nowotny P (1979) Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration. Diabetes 28: 577–584
Rizza R, Haymond M, Cryer P, Gerich J (1979) Differential effects of epinephrine on glucose production and disponsal in man. Am J Physiol 237: E356–362
Cori CF, Cori GF (1928) The mechanism of epinephrine action II. The influence of epinephrine and insulin on the carbohydrate metabolism of rats in the postabsorptive state. J Biol Chem 19: 321–341
Sacca L, Eigler N, Cryer PE, Sherwin RS (1979) Insulin antagonistic effects of epinephrine and glucagon in the dog. Am J Physiol 237: E487-E492
Houssay BA, Penhos JC (1956) Diabetogenic action of pituitary hormones on adrenalectomized hypophysectomized dogs. Endocrinology 59:637–641
Bratusch-Marrain P, DeFronzo RA (1983) Impairment of insulin mediated glucose metabolism by hyperosmolality in man. Diabetes 32:1028–1034
Komjati M (1982) Einfluß der Osmolalität auf Kohlenhydratstoffwechsel und Ketogenese in vivo. Thesis, TU Wien
Schmidt M, Hadji-Georgopoulos A, Rendell M, Margolis S, Kowarski A (1981) The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation. Diabetes Care 5: 579–585
Somogyi M (1938) Insulin as a cause of extreme hyperglycemia and instability. Bull St Louis Med Soc 32: 498–500
Boller R, Pilgerstorfer W (1938) Blutzuckerstudie über Protamin-Zink-Insulin. ZS Klin Med 134:300–320
Joslin EP, Gray H, Root HF (1922) Insulin in hospital and home. J Metab Res 2: 651–699
Molnar GD, Fatourechi V, Ackerman E, Taylor WF, Rosevear JW, Gatewood LC, Service FJ, Moxness KE (1971) Growth hormone and glucose interrelationships in diabetes: studies of inadvertent hypoglycemic episodes during continuous blood glucose analysis. J Clin Endocrinol Metab 32: 426–437
Olefsky S, Shreeve DR, Sutcliffe CH (1974) Brittle diabetes. Q J Med 43: 113–125
Bolli G, Irving S, Gottesman IS, Campbell PJ, Haymond MW, Cryer PE, Gerich JE (1984) Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia). N Engl J Med 311:1214–1219
Schmidt M, Hadji-Georgopoulos A, Rendell M, Margolis S, Kowarski D, Kowarski AA (1979) Fasting hyperglycemia and associated free insulin and cortisol changes in ‘Somogyi-like’ patients. Diabetes Care 2: 457–464
Bratusch-Marrain PR (1984) Die euglykämische Insulin- und hyperglykämische Clamp-Technik: Methoden zur Bestimmung der Insulinsensivität der Gewebe und der Glukosesensivität der Beta-Zelle. Infusionsther Klin Ernähr 11: 4–10
Bolli G, DeFeo P, DeCosmo S, Perriello G, Ventura M, Calcinaro F, Colli C, Campbell P, Brunetti P, Gerich J (1984) Demonstration of the dawn phenomenon in normal human volunteers. Diabetes 33: 1150–1153
Mauras N, Rogol AD, Clarke WL (1986) Failure to detect the dawn phenomenon in non-diabetic subjects with markedly different patterns of nocturnal growth hormone secretion. J Clin Endocrinol Metab 62: 975–979
Komjati M, Breitenecker F, Bratusch-Marrain P, Gampe J, Vierhapper H, Troch I, Waldhausl W (1985) Contribution by the glycogen pool and adenosine 3′5′-monophosphate release to the evanescent effect of glucagon on hepatic glucose production in vitro. Endocrinology 116: 978–986
Mintz DH, Finster JL, Taylor AL, Fefer A (1968) Hormonal genesis of glucose intolerance following hypoglycemia. Am J Med 45:187–197
Oakley NW, Jacobs HS, Turner RC, Williams J, Aquino CS, Nabarro JDN (1970) The effect of hypoglycemia on oral glucose tolerance in normal subjects and patients with pituitary and adrenal disorders. Clin Sci 39: 663–674
Waldhäusl W, Bratusch-Marrain P, Breitenecker F, Troch I, Komjati M (1984) Hyperglycemia and insulin deficiency is precipitated by stress hormone action. Diabetes 33 Supplement 1A
Waldhausl W (1986) Some physiologic aspects of blood glucose control. In: Serrono-Rios M, Lefèbvre PJ (eds) Diabetes 1985. International Congress Series 700, Excerpta Medica, Amsterdam pp 315–320
Carson ER, Cobelli C, Finkelstein L (1983) The mathematical modeling of metabolic and endocrine systems. Wiley, New York
Carson ER, Jones EA (1979) Use of kinetic analysis and mathematical modeling in the study of metabolic pathways in vivo. N Engl J Med 300: 1016–1027
Troch I, Breitenecker F, Gampe J, Komjati M, Bratusch-Marrain P, Waldhäusl W (1985) In: Javor AD (ed) Stimulation in research and development. Elsevier, Amsterdam, pp 103–117
Bessman SP, Renner VJ (1982) The biphasic hormonal nature of stress. In: Cowley RA, Trump BF (eds) Pathophysiology of shock, anoxia and ischemia, pp 60–75
Derfler K, Waldhäusl W, Zyman HJ, Howorka K, Holler C, Freyler H (1986) Diabetes care in a rural area: clinical and metabolic evaluation. Diabetes Care 9: 509–517
Sönksen PH, Judd SL, Lowy C (1978) Home monitoring of blood glucose. Method for improving diabetic control. Lancet 2: 729–732
Banting FG, Best CH (1922) The internal secretion of the pancreas. J Lab Clin Med 7: 251–266
Bernstein RK (1981) Diabetes: the glucograf method for normalizing blood sugar. Crown Publishers, New York
Czerwenka-Howorka K, Bratusch-Marrain P, Waldhäusl W (1984) Algorithmen der normoglykämischen Insulinsubstitution bei Typ 1 Diabetes. Erste Langzeitergebnisse. Wien Klin Wochenschr 96:558–559
Anonymous (1985) A practical guide to basal and prandial insulin-therapy. Diabetic Medicine 2: 45–53
Pickup JC, White MC, Keen H, Kohner EM, Parsons JA, Alberti KGMM (1979) Long term continuous subcutaneous insulin infusion in diabetics at home. Lancet 2: 870–873
Tamborlane WV, Sherwin RS, Genel M, Felig P (1979) Reduction to normal of plasma glucose in juvenile diabetics by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 300: 573–587
Irsigler K, Kritz H (1979) Long-term continuous intravenous insulin therapy with a portable insulin-dosage regulating apparatus. Diabetes 28:196–203
Waldhausl W, Freyler H, Bratusch-Marrain P, Vierhapper H, Bruneder H (1983) Kontinuierliche sukutane Insulininfusion. Langzeitbehandlung bei einer unausgewählien Gruppe insulin abhängiger Diabetiker. Deutsch Med Wochenschr 108: 570–577
Howorka K, Waldhausl W (1986) Feasibility of long-term near-normoglycaemic insulin substitution (NIS) by multiple injections. In: Proceedings of the 2nd Assisi International Symposium on Advanced Models for the Therapy of Insulin-Dependent Diabetes, 20–23.4.1986. Raven Press (in press)
Stolte K, Wolff J (1939) Die Behandlung der kindlichen Zuckerkrankheit mit freigewählter Kost. Erg Inn Med Kinderheilkd 56: 154–193
Schiffrin AD, DesRosiers M, Moffat M, Belmonte MM (1983) Feasibility of strict diabetes control in insulin dependent diabetic adolescents. J Paediatr 103: 522–527
Teutsch SM, Hermann WH, Dwyer DM, Lane JM (1984) Mortality among diabetic patients using continuous subcutaneous insulin infusion pumps. N Engl J Med 310: 361–368
Assal JP, Mühlhauser I, Pernet A, Gfeller R, Jörgens V, Berger M (1985) Patient education as the basis for diabetes care in clinical practice and research. Diabetologia 28: 602–613
Mühlhauser I, Jörgens V, Berger M, Graninger W, Gürtler W, Hornke L, Kunz A, Schernthaner G, Scholz V, Voss HE (1983) Bicentric evaluation of a teaching and treatment programme for Type 1 (insulin dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 25: 470–476
Schade DS, Duckworth WC (1986) In search of the subcutaneous insulin resistance syndrome. N Engl J Med 315: 147–153
Author information
Authors and Affiliations
Additional information
18th Claude Bernard Lecture of the European Association for the Study of Diabetes delivered in Rome, Italy, 20 September 1986
Rights and permissions
About this article
Cite this article
Waldhäusl, W.K. The physiological basis of insulin treatment — clinical aspects. Diabetologia 29, 837–849 (1986). https://doi.org/10.1007/BF00870138
Issue Date:
DOI: https://doi.org/10.1007/BF00870138